Cyclo Therapeutics, Inc. (CYTH)

Cyclo Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 26, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	21	45	12	31	19	41
Market Cap Growth	-17.49%	277.44%	-61.58%	64.74%	-53.83%	-43.29%
Enterprise Value	32	44	8	23	17	36
Last Close Price	0.72	1.59	1.42	3.73	4.35	34.00
PS Ratio	22.38	42.23	8.76	19.77	21.07	40.92
PB Ratio	-1.54	9.56	16.40	2.00	1.82	44.03
P/TBV Ratio	-	9.56	16.40	2.00	1.82	44.03
EV/Sales Ratio	36.74	40.60	5.64	14.56	18.81	36.02
Debt / Equity Ratio	-0.91	0.22	-	0.01	0.02	0.06
Asset Turnover	0.16	0.12	0.12	0.09	0.10	0.29
Inventory Turnover	0.34	0.39	0.62	0.72	0.31	0.72
Quick Ratio	0.06	1.11	0.46	4.47	3.52	0.93
Current Ratio	0.17	1.46	1.20	5.07	3.83	1.26
Return on Equity (ROE)	-	-730.48%	-188.35%	-109.37%	-157.03%	-781.18%
Return on Assets (ROA)	-284.27%	-143.52%	-82.27%	-52.99%	-61.21%	-134.13%
Return on Capital (ROIC)	-	-384.12%	-117.80%	-67.43%	-96.27%	-476.05%
Earnings Yield	-119.73%	-44.12%	-128.28%	-45.57%	-46.99%	-18.28%
FCF Yield	-108.72%	-35.61%	-125.62%	-47.93%	-45.16%	-15.99%
Buyback Yield / Dilution	-109.38%	-93.50%	-32.48%	-298.32%	-47.81%	-32.33%

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q